300947 Fair Value & Analysis
Industrials · CN · Market cap 2.1B CNY
Fair value as of: Jul 24, 2026
From 14 valuation models · updated 17 days ago
Share price +15.6% over the past month.
A solid business, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Our model range runs from ¥11.18 (bear) to ¥17.86 (bull), base ¥14.52. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 50/100 (solid quality) with medium evidence: read the verdict with care.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 24, 2026.
How to read this chart
60‑month range ¥7.97 – ¥33.11 · fair‑value band ¥11.18 – ¥17.86 · the ¥14.51 price screens below the ¥14.52 fair value. Dashed = 300-day average. As of Jul 24, 2026.
Analysis
300947 (300947) currently trades at ¥14.51, while our model-based Fair Value estimate is ¥14.52, implying the stock looks roughly 0.1% fairly valued today. The Quality Score stands at 50/100 (solid quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, 300947 generated revenue of 1.2B CNY at a net margin of -5.1%. Revenue declined 3.1% year over year. It earns a return on equity of -6.4%. Fundamentals as of Jul 24, 2026
Our scenario range runs from ¥11.18 (bear case) to ¥17.86 (bull case); at ¥14.51, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 50% below its 52-week high and 8% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -35% fair-value upside, at 0%, 300947 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 14 models by family
Widest divergence: DCF Models (¥35.88) versus Asset-Based (¥5.25). Highest evidence: Growth DCF (80).
Notify me when 300947 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 24, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 50 · Market factors (momentum, volatility) 21
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Shanghai DOBE Cultural & Creative Industry Development (Group)Co. LTD. engages in the design, investment, management, and operation of cultural and creative industrial parks in China and internationally.
Full company description
Shanghai DOBE Cultural & Creative Industry Development (Group)Co. LTD. engages in the design, investment, management, and operation of cultural and creative industrial parks in China and internationally. It also provides financial leasing and business services; merchant agency and design services; catering and business services; real estate services; internet and related services; and accommodation, physical education, merchant agency, technology promotion and application, and software and information technology services. In addition, it is involved in the production and supply of electricity and heat. The company was founded in 2011 and is based in Shanghai, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
300947 reported revenue of ¥1.2B in FY2025 versus ¥955M in FY2021, a compound +6.4%/yr. Reported net income was −¥57.9M in FY2025.
Watch 300947: get an alert when its fair value changes →
Peer Group
Specialty Business Services · 253 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Business Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate (as of Jul 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Cintas Corporation CTAS | $206.25 | $95.30 | -54% |
| RELX PLC RELX | $33.70 | $32.49 | -4% |
| Thomson Reuters Corporation TRI | C$133.87 | C$70.40 | -47% |
| Copart, Inc CPRT | $27.61 | $28.59 | +4% |
| Global Payments Inc GPN | $80.49 | $69.67 | -13% |
| RB Global, Inc RBA | C$156.43 | C$49.14 | -69% |
| Brambles Limited BXB | A$18.79 | A$12.28 | -35% |
| UL Solutions Inc ULS | $87.76 | $33.62 | -62% |
| Wolters Kluwer N.V WKL | €62.56 | €103.99 | +66% |
| Aramark ARMK | $56.74 | $13.73 | -76% |
Compare 300947 with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is 300947 overvalued or undervalued?
What is the fair value of 300947?
What is the quality score of 300947?
What is the revenue of 300947?
What is the net profit margin of 300947?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track 300947 and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.